A post COVID-19 'Marshall Plan' for type 2 diabetes.

Petrie, John R; Boyle, James G; Ali, Kashif; Smith, Christopher; Morrison, Deborah; Kar, Partha

Petrie, John R; Boyle, James G; Ali, Kashif; Smith, Christopher; Morrison, Deborah; Kar, Partha.

Petrie JR; University of Glasgow, Glasgow, UK.
Boyle JG; University of Glasgow, Glasgow, UK.
Ali K; NHS Greater Glasgow and Clyde, Glasgow, UK.
Smith C; NHS Greater Glasgow and Clyde, Glasgow, UK.
Morrison D; NHS Greater Glasgow and Clyde, Glasgow, UK.
Kar P; NHS Greater Glasgow and Clyde, Glasgow, UK.

Diabet Med ; 38(1): e14439, 2021 01.

Article in English | MEDLINE | ID: covidwho-892248

Subject(s)

COVID-19/epidemiology; Diabetes Mellitus, Type 2/epidemiology; Diabetes Mellitus, Type 2/prevention & control; SARS-CoV-2; Comorbidity; Delivery of Health Care/methods; Diabetes Complications/epidemiology; Diabetes Complications/prevention & control; Diabetes Complications/therapy; Diabetes Mellitus, Type 2/therapy; Hospitalization; Humans; United Kingdom/epidemiology

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Diabetes Mellitus, Type 2 / SARS-CoV-2 / COVID-19 Type of study: Observational study / Prognostic study Topics: Long Covid Limits: Humans Country/Region as subject: Europa Language: English Journal: Diabet Med Journal subject: Endocrinology Year: 2021 Document Type: Article Affiliation country: Dme.14439

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google